Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 6

1.

Effect of octreotide LAR dose and weight on octreotide blood levels in patients with neuroendocrine tumors.

Woltering EA, Mamikunian PM, Zietz S, Krutzik SR, Go VL, Vinik AI, Vinik E, O'Dorisio TM, Mamikunian G.

Pancreas. 2005 Nov;31(4):392-400.

PMID:
16258376
[PubMed - indexed for MEDLINE]
2.

Octreotide acetate long-acting formulation versus open-label subcutaneous octreotide acetate in malignant carcinoid syndrome.

Rubin J, Ajani J, Schirmer W, Venook AP, Bukowski R, Pommier R, Saltz L, Dandona P, Anthony L.

J Clin Oncol. 1999 Feb;17(2):600-6.

PMID:
10080605
[PubMed - indexed for MEDLINE]
Free Article
3.

Characterization of somatostatin receptors on human neuroblastoma tumors.

O'Dorisio MS, Chen F, O'Dorisio TM, Wray D, Qualman SJ.

Cell Growth Differ. 1994 Jan;5(1):1-8.

PMID:
8123588
[PubMed - indexed for MEDLINE]
Free Article
4.

Somatostatin receptors, adenylate cyclase activity, and growth hormone (GH) response to octreotide in GH-secreting adenomas.

Bertherat J, Chanson P, Dewailly D, Dupuy M, Jaquet P, Peillon F, Epelbaum J.

J Clin Endocrinol Metab. 1993 Dec;77(6):1577-83.

PMID:
7903312
[PubMed - indexed for MEDLINE]
5.

Consensus statement: octreotide dose titration in secretory diarrhea. Diarrhea Management Consensus Development Panel.

Harris AG, O'Dorisio TM, Woltering EA, Anthony LB, Burton FR, Geller RB, Grendell JH, Levin B, Redfern JS.

Dig Dis Sci. 1995 Jul;40(7):1464-73. Review.

PMID:
7628270
[PubMed - indexed for MEDLINE]
6.

Antiproliferative effects of the somatostatin analogue octreotide (SMS 201-995) on ZR-75-1 human breast cancer cells in vivo and in vitro.

Weckbecker G, Liu R, Tolcsvai L, Bruns C.

Cancer Res. 1992 Sep 15;52(18):4973-8.

PMID:
1325289
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk